Article info
PDFBasic and translational research
Extended report
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts
- Correspondence to Dr Kerstin Klein, Center of Experimental Rheumatology, University Hospital Zurich, Wagistrasse 14, Zurich-Schlieren CH-8952, Switzerland; kerstin.klein{at}usz.ch
Citation
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts
Publication history
- Received April 25, 2014
- Revised October 29, 2014
- Accepted November 7, 2014
- First published December 2, 2014.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/